The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Role of Oxidative Stress in the Progression of Alzheimer's Disease
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized pathologically by the presence of senile plaques, neurofibrillary tangles, and synapse loss. Increasing evidence supports a role of amyloid beta-peptide (Abeta)-induced oxidative stress in the progression and pathogenesis of AD. In this review, we summarize evidence for a role of oxidative stress in the progression of AD by comparing the appearance of the same oxidized brain proteins from subjects with mild cognitive impairment (MCI), early AD (EAD), and late-stage AD, and relating these findings to the reported AD pathology. The identification of oxidized brain proteins in common in MCI, EAD, and AD brain suggest that certain key pathways are triggered and may be involved in the progression of AD. Exploring these pathways in detail may provide clues for better understanding the pathogenesis and progression of AD and also for the development of effective therapies to treat or delay this dementing disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation
Coyle, J. T., Price, D. L., & DeLong, M. R. (1983) · Science · doi:10.1126/science.6338589 · Cited by 3,052
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., & Glabe, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500997200 · Cited by 1,041
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 1×
“However, the levels of soluble A β are directly correlated with the decline in cognitive impairment, suggesting that small oligomers of A β are the actual toxic species of this peptide rather than fibrillar A β [12–18].”
Cutler, R. G., Kelly, J., Storie, K., Pedersen, W. A., Tammara, A., Hatanpaa, K., Troncoso, J. C., & Mattson, M. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305799101 · Cited by 1,008
Sayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,001
Self-citationOxidative Damage and Tyrosine Nitration from Peroxynitrite
Beckman, J. S. (1996) · Chemical Research in Toxicology · doi:10.1021/tx9501445 · Cited by 992
A human peptidyl–prolyl isomerase essential for regulation of mitosis
Ping Lu, K., Hanes, S. D., & Hunter, T. (1996) · Nature · doi:10.1038/380544a0 · Cited by 904
Membrane proteins and proteomics: Un amour impossible?
Santoni, V., Molloy, M., & Rabilloud, T. (2000) · Electrophoresis · doi:10.1002/(sici)1522-2683(20000401)21:6<1054::aid-elps1054>3.0.co;2-8 · Cited by 852
Multifunctional α-enolase: its role in diseases
Pancholi, V. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000910 · Cited by 838
HUMAN CARBONIC ANHYDRASES AND CARBONIC ANHYDRASE DEFICIENCIES
Sly, W. S., & Hu, P. Y. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.002111 · Cited by 830
Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T., & Mufson, E. J. (2007) · Neurology · doi:10.1212/01.wnl.0000260698.46517.8f · Cited by 824
Allan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · cited 3×
“Studies have shown increased protein carbonyls in the hippocampus and parietal cortex, the regions of the brain that are severely affected in AD, but not in the cerebellum where there is less significant AD pathology [47].”
Self-citationMark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 779
Neuron numbers and dendritic extent in normal aging and Alzheimer’s disease
Coleman, P. D., & Flood, D. G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90127-8 · Cited by 772
RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease
Nunomura, A., Perry, G., Pappolla, M. A., Wade, R., Hirai, K., Chiba, S., & Smith, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01959.1999 · Cited by 722
ALLANBUTTERFIELD, D., CASTEGNA, A., LAUDERBACK, C., & DRAKE, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5710 · Cited by 714
Lo, T. W., Westwood, M. E., McLellan, A. C., Selwood, T., & Thornalley, P. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31635-1 · Cited by 693
Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680
Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts
G�thel, S. F., & Marahiel, M. A. (1999) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050299 · Cited by 647
Mitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 607
Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease
Mosconi, L., Pupi, A., & De Leon, M. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.007 · Cited by 595
Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581
Self-citationCastegna, A., Aksenov, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01103.x · Cited by 581
Self-citationPerry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E., & Perry, R. H. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.413 · Cited by 571
Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564
Self-citationSpires, T. L., Meyer-Luehmann, M., Stern, E. A., McLean, P. J., Skoch, J., Nguyen, P. T., Bacskai, B. J., & Hyman, B. T. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1879-05.2005 · Cited by 550 · cited 1×
“The oxidative modification and altered functionof these proteins couldcontributeto the report-ed loss of interneuronalconnections,shorteneddendrit-ic length, impaired axonal transport, and loss of neuronal structural integrity in AD brain [107–109].”
Pin1-Dependent Prolyl Isomerization Regulates Dephosphorylation of Cdc25C and Tau Proteins
Zhou, X. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00085-x · Cited by 544
Evidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
Self-citationProteomic identification of nitrated proteins in Alzheimer's disease brain
Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B., Markesbery, W. R., & Butterfield, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01786.x · Cited by 535
Self-citationAmyloid-β oligomers: their production, toxicity and therapeutic inhibition
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Rowan, M. J., & Selkoe, D. J. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300552 · Cited by 507
Hensley, K., Maidt, M. L., Yu, Z., Sang, H., Markesbery, W. R., & Floyd, R. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08126.1998 · Cited by 507
The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production
Pastorino, L., Sun, A., Lu, P.-J., Zhou, X. Z., Balastik, M., Finn, G., Wulf, G., Lim, J., Li, S.-H., Li, X., et al. (2006) · Nature · doi:10.1038/nature04543 · Cited by 487 · cited 2×
“Pin-1 has been shown to bind to AβPP and regulate the production of Aβ [89,91], and via its action on both kinases and phosphatases, Pin-1 also regulates the phosphorylation of tau protein [89, 93].”
Increased Nuclear DNA Oxidation in the Brain in Alzheimer's Disease
Gabbita, S. P., Lovell, M. A., & Markesbery, W. R. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052034.x · Cited by 478
Stable markers of oxidant damage to proteins and their application in the study of human disease
Davies, M. J., Fu, S., Wang, H., & Dean, R. T. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00206-3 · Cited by 461
Neuropathologic Substrate of Mild Cognitive Impairment
Markesbery, W. R., Schmitt, F. A., Kryscio, R. J., Davis, D. G., Smith, C. D., & Wekstein, D. R. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.38 · Cited by 460 · cited 1×
“Further, brains from subjects with EAD showed increased number of neurofibrillary tangles compared toMCI patients in the frontal and temporal lobes [9] and also”
Acrolein is increased in Alzheimer’s disease brain and is toxic to primary hippocampal cultures
Lovell, M. A., Xie, C., & Markesbery, W. R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00235-9 · Cited by 450
Dalle‐Donne, I., Scaloni, A., Giustarini, D., Cavarra, E., Tell, G., Lungarella, G., Colombo, R., Rossi, R., & Milzani, A. (2005) · Mass Spectrometry Reviews · doi:10.1002/mas.20006 · Cited by 448
Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration
Liou, Y.-C., Sun, A., Ryo, A., Zhou, X. Z., Yu, Z.-X., Huang, H.-K., Uchida, T., Bronson, R., Bing, G., Li, X., et al. (2003) · Nature · doi:10.1038/nature01832 · Cited by 435
Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease
Lovell, M. A., Ehmann, W. D., Mattson, M. P., & Markesbery, W. R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00108-5 · Cited by 412
Mild cognitive impairment: transition between aging and Alzheimer's disease.
Petersen, R. C. (2000) · PubMed · Cited by 395
Williams, T. I., Lynn, B. C., Markesbery, W. R., & Lovell, M. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.004 · Cited by 392
Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377
Self-citationMethylglyoxal Modification of Protein
Oya, T., Hattori, N., Mizuno, Y., Miyata, S., Maeda, S., Osawa, T., & Uchida, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18492 · Cited by 377
Drake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371
Identification of nitrated proteins in Alzheimer’s disease brain using a redox proteomics approach
Sultana, R., Poon, H. F., Cai, J., Pierce, W. M., Merchant, M., Klein, J. B., Markesbery, W. R., & Butterfield, D. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.10.004 · Cited by 364
Self-citationAdvances in Alzheimer's disease
Katzman, R., & Saitoh, T. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.3.2001787 · Cited by 357
Oda, T., Wals, P., Osterburg, H. H., Johnson, S. A., Pasinetti, G. M., Morgan, T. E., Rozovsky, I., Stine, W. B., Snyder, S. W., Holzman, T. F., et al. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1080 · Cited by 352
Sultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J., Pierce, W. M., Klein, J. B., Merchant, M., Markesbery, W. R., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.021 · Cited by 335
Self-citation4-Hydroxynonenal and neurodegenerative diseases
Zarkovic, K. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00024-4 · Cited by 315
Lovell, M. A., Gabbita, S. P., & Markesbery, W. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720771.x · Cited by 291
Jeganathan, S., von Bergen, M., Mandelkow, E.-M., & Mandelkow, E. (2008) · Biochemistry · doi:10.1021/bi800783d · Cited by 286 · cited 1×
“pairment of the mitochondrial proton gradient for ATP synthesis and may also lead to increased aggregation of proteins as seen in AD [41,124,125].”
Sultana, R., Ravagna, A., Mohmmad‐Abdul, H., Calabrese, V., & Butterfield, D. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02899.x · Cited by 276
Self-citationLipid peroxidation is an early event in the brain in amnestic mild cognitive impairment
Markesbery, W. R., Kryscio, R. J., Lovell, M. A., & Morrow, J. D. (2005) · Annals of Neurology · doi:10.1002/ana.20629 · Cited by 273
Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., & Butterfield, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031161.x · Cited by 270
Self-citationButterfield, D. A., & Boyd‐Kimball, D. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00087.x · Cited by 263
Self-citationOxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients
Migliore, L., Fontana, I., Trippi, F., Colognato, R., Coppedè, F., Tognoni, G., Nucciarone, B., & Siciliano, G. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.016 · Cited by 263
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment
Wang, J., Markesbery, W. R., & Lovell, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03615.x · Cited by 260
Reed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257
Self-citationSultana, R., Boyd-Kimball, D., Poon, H. F., Cai, J., Pierce, W. M., Klein, J. B., Markesbery, W. R., Zhou, X. Z., Lu, K. P., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.005 · Cited by 253
Self-citationMcGrath, L. T. (2001) · QJM · doi:10.1093/qjmed/94.9.485 · Cited by 251
Butterfield, D. A., Reed, T., Perluigi, M., De Marco, C., Coccia, R., Cini, C., & Sultana, R. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.017 · Cited by 246
Self-citationYatin, S. M., Varadarajan, S., & Butterfield, D. A. (2000) · Journal of Alzheimer's Disease · doi:10.3233/jad-2000-2212 · Cited by 239
Self-citationOxidative imbalance in patients with mild cognitive impairment and Alzheimer’s disease
GUIDI, I., GALIMBERTI, D., LONATI, S., NOVEMBRINO, C., BAMONTI, F., TIRITICCO, M., FENOGLIO, C., VENTURELLI, E., BARON, P., & BRESOLIN, N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.001 · Cited by 203
Cholinergic Neuronal and Axonal Abnormalities Are Present Early in Aging and in Alzheimer Disease
Geula, C., Nagykery, N., Nicholas, A., & Wu, C.-K. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a1df3 · Cited by 202
Perluigi, M., Sultana, R., Cenini, G., Di Domenico, F., Memo, M., Pierce, W. M., Coccia, R., & Butterfield, D. A. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800161 · Cited by 196
Self-citationButterfield, D. A., Hensley, K., Cole, P., Subramaniam, R., Aksenov, M., Aksenova, M., Bummer, P. M., Haley, B. E., & Carney, J. M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062451.x · Cited by 191
Self-citationReed, T. T., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2009) · Brain Research · doi:10.1016/j.brainres.2009.04.009 · Cited by 190
The Identification and Characterization of Oxidized RNAs in Alzheimer's Disease
Shan, X., Tashiro, H., & Lin, C.-L. G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04913.2003 · Cited by 185
Redox proteomics: from protein modifications to cellular dysfunction and disease
Butterfield, D. A., & Dalle‐Donne, I. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21404 · Cited by 182
Self-citationHoyer, S. (2004) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-8969-7_8 · Cited by 174
Tohgi, H., Abe, T., Yamazaki, K., Murata, T., Ishizaki, E., & Isobe, C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00406-1 · Cited by 173
Boyd-Kimball, D., Sultana, R., Fai Poon, H., Lynn, B. C., Casamenti, F., Pepeu, G., Klein, J. B., & Butterfield, D. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.022 · Cited by 166
Self-citationLovell, M. A., & Markesbery, W. R. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.392 · Cited by 163
Power, J. H. T., Asad, S., Chataway, T., Chegini, F., Manavis, J., Temlett, J. A., Jensen, P. H., Blumbergs, P. C., & Gai, W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0373-3 · Cited by 160
β-Amyloid Mediated Nitration of Manganese Superoxide Dismutase
Muthuswamy, A., Tangpong, J., Keller, J. N., Murphy, M. P., Markesbery, W. R., Kiningham, K. K., & Clair, D. K. S. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051223 · Cited by 156
Debra Boyd-kimball, A., Castegna, A., Rukhsana Sultana, A., Poon, H. F., Petroze, R. T., Lynn, B. C., Klein, J. B., & Butterfield, D. A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.086 · Cited by 153
Self-citationNeurochemical enzyme changes in Alzheimer's and Pick's disease
Meier‐Ruge, W., Iwangoff, P., & Reichlmeier, K. (1984) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(84)90007-4 · Cited by 146
Decreased RNA, and Increased RNA Oxidation, in Ribosomes from Early Alzheimer’s Disease
Ding, Q., Markesbery, W. R., Cecarini, V., & Keller, J. N. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9071-5 · Cited by 140
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease
Nunomura, A., Chiba, S., Lippa, C. F., Cras, P. P., Kalaria, R. N., Takeda, A., Honda, K., Smith, M. A., & Perry, G. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.003 · Cited by 136
Reed, T. T., Pierce Jr., W. M., Turner, D. M., Markesbery, W. R., & Allan Butterfield, D. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00478.x · Cited by 135
Lübec, G., Nonaka, M., Krapfenbauer, K., Gratzer, M., Cairns, N. J., & Fountoulakis, M. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_10 · Cited by 128
Quantification of oxidized RNAs in Alzheimer's disease
Shan, X., & Lin, C.-L. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.022 · Cited by 125
Abe, T., Tohgi, H., Isobe, C., Murata, T., & Sato, C. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10349 · Cited by 124
Abdul, H. M., Rukhsana Sultana, A., Keller, J. N., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03647.x · Cited by 124
Self-citationLange, M. L. B., Cenini, G., Piroddi, M., Abdul, H. M., Rukhsana Sultana, A., Galli, F., Memo, M., & Butterfield, D. A. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.004 · Cited by 118
Self-citationCastegna, A., Lauderback, C. M., Abdul, H. M., & Butterfield, D. A. (2004) · Brain Research · doi:10.1016/j.brainres.2004.01.036 · Cited by 118
Self-citationRukhsana Sultana, A., Piroddi, M., Galli, F., & Butterfield, D. A. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9593-0 · Cited by 117
Self-citationThe 1999 SWISS-2DPAGE database update
Hoogland, C., Sanchez, J. C., Tonella, L., Binz, P. A., Bairoch, A., Hochstrasser, D. F., & Appel, R. D. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.286 · Cited by 110
Glutamine synthetase (GS) expression is reduced in senile dementia of the Alzheimer type
Prince, G. L., Delaère, P., Fages, C., Lefrançois, T., Touret, M., Salanon, M., & Tardy, M. (1995) · Neurochemical Research · doi:10.1007/bf00969698 · Cited by 107
Why Alzheimer's is a disease of memory: The attack on synapses by Aß oligomers (ADDLs)
Viola, K. L., Velasco, P. T., & Klein, W. L. (2008) · The journal of nutrition health & aging · doi:10.1007/bf02982587 · Cited by 106
Boyd-Kimball, D., Poon, H. F., Lynn, B. C., Cai, J., Pierce Jr., W. M., Klein, J. B., Ferguson, J., Link, C. D., & Butterfield, D. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.07.001 · Cited by 98
Oxidatively modified RNA in mild cognitive impairment
Lovell, M. A., & Markesbery, W. R. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.030 · Cited by 98
Inverse association of Pin1 and tau accumulation in Alzheimer's disease hippocampus
Holzer, M., Gärtner, U., Stöbe, A., Härtig, W., Gruschka, H., Brückner, M. K., & Arendt, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0581-1 · Cited by 90
Abdul, H. M., & Butterfield, D. A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.12.002 · Cited by 89
Self-citationSultana, R., Reed, T., Perluigi, M., Coccia, R., Pierce, W. M., & Butterfield, D. A. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00065.x · Cited by 87
Self-citationMaki, M., Matsukawa, N., Yuasa, H., Otsuka, Y., Yamamoto, T., Akatsu, H., Okamoto, T., Ueda, R., & Ojika, K. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.2.176 · Cited by 86
Pin1 allows for differential Tau dephosphorylation in neuronal cells
Hamdane, M., Dourlen, P., Bretteville, A., Sambo, A., Ferreira, S., Ando, K., Kerdraon, O., Bégard, S., Geay, L., Lippens, G. M., et al. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.03.006 · Cited by 86
Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies
Ramakrishnan, P., Dickson, D. W., & Davies, P. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00109-8 · Cited by 84
Oikawa, S., Yamada, T., Minohata, T., Kobayashi, H., Furukawa, A., Tada‐Oikawa, S., Hiraku, Y., Murata, M., Kikuchi, M., & Yamashima, T. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.029 · Cited by 82
Tremblay, C., Pilote, M., Phivilay, A., Émond, V., Bennett, D. A., & Calon, F. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12411 · Cited by 81
Lafon‐Cazal, M., Fagni, L., Guiraud, M., Mary, S., Lerner‐Natoli, M., Pin, J., Shigemoto, R., & Bockaert, J. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00475.x · Cited by 81
Rukhsana Sultana, A., Marzia Perluigi, A., & Butterfield, D. A. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.09.024 · Cited by 80
Self-citationAbdul, H. M., Wenk, G. L., Gramling, M., Hauss‐Wegrzyniak, B., & Butterfield, D. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.077 · Cited by 70
Self-citationRapoport, S. I. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/pl00014174 · Cited by 69
Lambert, J.-C., Mann, D. M. A., Harris, J. M., Chartier-Harlin, M.-C., Cumming, A., Coates, J., Lemmon, H., StClair, D., Iwatsubo, T., & Lendon, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.6.353 · Cited by 61
牧, 美. (2002) · Medical Entomology and Zoology · Cited by 58
Rukhsana Sultana, A., & Butterfield, D. A. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9123-x · Cited by 52
Self-citationAlzheimer's disease and the cell cycle
Raina, A. K., Zhu, X., & Smith, M. A. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1496 · Cited by 49
Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia
Pametti, L., Palumbo, B., Cardinali, L., Loreti, F., Chionne, F., Cecchetti, R., & Senin, U. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11110-5 · Cited by 44
Early‐onset Alzheimer's disease: An analysis of CT findings
Drayer, B. P., Heyman, A., Wilkinson, W. E., Barrett, L., & Weinberg, T. (1985) · Annals of Neurology · doi:10.1002/ana.410170420 · Cited by 40
Farrow, T. F. D., Thiyagesh, S. N., Wilkinson, I. D., Parks, R. W., Ingram, L., & Woodruff, P. W. R. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.12.013 · Cited by 38
Classical Alzheimer features and cholinergic dysfunction: towards a unifying hypothesis?
Wevers, A., Witter, B., Moser, N., Burghaus, L., Banerjee, C., Steinlein, O. K., Schütz, U., de Vos, R. A. I., Steur, E. N. H. J., Lindstrom, J. M., et al. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00306.x · Cited by 25
[Hippocampal cholinergic neurostimulating peptide].
Ojika, K. (1998) · PubMed · Cited by 23
[What is a mild cognitive impairment?].
Portet, F., Ousset, P., & Touchon, J. (2005) · PubMed · Cited by 11
Cited by
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377
Oxidative Stress in Neurodegenerative Diseases
Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9337-5 · Cited by 800
Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526
Self-citationSultana, R., Perluigi, M., & Butterfield, D. A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.027 · Cited by 478
Self-citationLeón, R., Garcia, A. G., & Marco‐Contelles, J. (2013) · Medicinal Research Reviews · doi:10.1002/med.20248 · Cited by 440
Metadata
- Authors
- Sultana, R., & Butterfield, D. A.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-01-06
- Volume
- 19
- Issue
- 1
- Pages
- 341-353
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1492443634
- Cited by
- 327
- References
- 127
- FWCI
- 18.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.